BASHIR AL KADDOUMI, M.B, B.S, M.D.
Cardiovascular Disease Physician in HOUSTON, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What stands out: BASHIR AL KADDOUMI, M.B, B.S, M.D. reported a CMS MIPS final score of 75 out of 100, below the 83.1 national average, and filed 2,714 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.
BASHIR AL KADDOUMI, M.B, B.S, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
BASHIR AL KADDOUMI, M.B, B.S, M.D. at a glance
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Texas
How Cardiovascular Disease Physician compares to other specialties among Texas providers
Cardiovascular Disease Physician share within Texas
Cardiovascular Disease Physician is one of the more visible NUCC categories in Texas
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
BASHIR AL KADDOUMI, M.B, B.S, M.D.'s 2023 MIPS final score plotted against the Cardiovascular Disease Physician national average
- MIPS Final Score
- 75/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Cardiovascular Disease Physician) — 75/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Specialty volume Cardiovascular Disease Physician US NPIs
75/100 MIPS final score — 8.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Cardiovascular Disease Physician.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
BASHIR AL KADDOUMI, M.B, B.S, M.D. is a Cardiovascular Disease Physician provider practicing in HOUSTON, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.B, B.S, M.D.. NPI: 1194996702. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.
BASHIR AL KADDOUMI, M.B, B.S, M.D. appears in the CMS NPPES registry as a Cardiovascular Disease Physician provider holding M.B, B.S, M.D. credentials at 18220 STATE HIGHWAY 249, HOUSTON, TX, 77070, with a listed phone of (832) 241-2001. NPI 1194996702 was issued on 03/23/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what AL KADDOUMI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,714 prescription claims written by this provider, covering 317 Medicare beneficiaries and totaling roughly $398K in drug spend, split 13% brand-name and 87% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.
Cardiovascular Disease Physician is a mid-sized specialty nationwide, with 24,795 enrolled providers across 54 states and an average of 3,033 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1194996702 |
|---|---|
| Specialty | Cardiovascular Disease Physician |
| Credentials | M.B, B.S, M.D. |
| Gender | Male |
| NPI Issued | 03/23/2008 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm BASHIR AL KADDOUMI, M.B, B.S, M.D.'s current license status, disciplinary history, and board certifications with the Texas Medical Board in Texas before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for BASHIR AL KADDOUMI, M.B, B.S, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.2K
Largest payer
Boston Scientific Corporation
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context — Texas TMB 2023 annual report
Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to BASHIR AL KADDOUMI, M.B, B.S, M.D.. To verify BASHIR AL KADDOUMI, M.B, B.S, M.D.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Typical
13% brand-name claims vs 87% generic, on 2,714 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 6,959
- Total Day Supply
- 207,953
- Brand vs Generic
- 13% brand / 87% generic
- Brand Drug Cost
- $352K
- Generic Drug Cost
- $46K
Patient Demographics
- Average Patient Age
- 73.2 years
- Avg HCC Risk Score
- 1.82
- Gender Split
- 53% female / 47% male
- Age Distribution
- <65: 29, 65-74: 155, 75-84: 102, 85+: 31
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
| Drug | Claims |
|---|---|
| Metoprolol Succinate | 264 |
| Atorvastatin Calcium | 254 |
| Clopidogrel Clopidogrel Bisulfate | 234 |
| Losartan Potassium | 164 |
| Furosemide | 140 |
| Lisinopril | 135 |
| Hydrochlorothiazide | 134 |
| Amlodipine Besylate | 133 |
| Rosuvastatin Calcium | 132 |
| Eliquis Apixaban | 126 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Cardiovascular Disease Physician Overview
How BASHIR AL KADDOUMI, M.B, B.S, M.D. fits within the Cardiovascular Disease Physician landscape nationally.
BASHIR AL KADDOUMI, M.B, B.S, M.D.'s 2,714 claims are below the specialty average of 3,033.
Nearby Cardiovascular Disease Physician Providers in Texas
Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as AL KADDOUMI.
Compare Cardiovascular Disease Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Texas
Frequently Asked Questions
What is BASHIR AL KADDOUMI, M.B, B.S, M.D.'s specialty? ▼
How much does BASHIR AL KADDOUMI, M.B, B.S, M.D. prescribe under Medicare Part D? ▼
What is BASHIR AL KADDOUMI, M.B, B.S, M.D.'s Medicare quality score? ▼
Where is BASHIR AL KADDOUMI, M.B, B.S, M.D. located? ▼
What is BASHIR AL KADDOUMI, M.B, B.S, M.D.'s NPI number? ▼
Does BASHIR AL KADDOUMI, M.B, B.S, M.D. prescribe more brand-name or generic drugs? ▼
How many Cardiovascular Disease Physician providers are there in the US? ▼
What drugs does BASHIR AL KADDOUMI, M.B, B.S, M.D. prescribe most often? ▼
Does BASHIR AL KADDOUMI, M.B, B.S, M.D. accept Medicare? ▼
How can I verify BASHIR AL KADDOUMI, M.B, B.S, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology